|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:UGDH-RFC1 (FusionGDB2 ID:95969) |
Fusion Gene Summary for UGDH-RFC1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: UGDH-RFC1 | Fusion gene ID: 95969 | Hgene | Tgene | Gene symbol | UGDH | RFC1 | Gene ID | 7358 | 6573 |
Gene name | UDP-glucose 6-dehydrogenase | solute carrier family 19 member 1 | |
Synonyms | EIEE84|GDH|UDP-GlcDH|UDPGDH|UGD | CHMD|FOLT|IFC-1|IFC1|REFC|RFC|RFC1|RFT-1|hRFC|hSLC19A1 | |
Cytomap | 4p14 | 21q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | UDP-glucose 6-dehydrogenaseUDP-Glc dehydrogenaseUDP-glucose dehydrogenaseuridine diphospho-glucose dehydrogenase | reduced folate transporterfolate transporter 1intestinal folate carrier 1placental folate transporterreduced folate carrier 1reduced folate carrier proteinreduced folate transporter 1solute carrier family 19 (folate transporter), member 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000316423, ENST00000501493, ENST00000506179, ENST00000507089, ENST00000515398, | ENST00000349703, ENST00000381897, ENST00000418436, | |
Fusion gene scores | * DoF score | 6 X 6 X 5=180 | 5 X 5 X 3=75 |
# samples | 7 | 5 | |
** MAII score | log2(7/180*10)=-1.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: UGDH [Title/Abstract] AND RFC1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | UGDH(39522970)-RFC1(39322994), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | UGDH-RFC1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. UGDH-RFC1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. UGDH-RFC1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | UGDH | GO:0006065 | UDP-glucuronate biosynthetic process | 27966912 |
Hgene | UGDH | GO:0034214 | protein hexamerization | 27966912 |
Tgene | RFC1 | GO:0051958 | methotrexate transport | 22554803 |
Tgene | RFC1 | GO:0098838 | folate transmembrane transport | 22554803 |
Tgene | RFC1 | GO:1904447 | folate import across plasma membrane | 14609557|22554803 |
Fusion gene breakpoints across UGDH (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across RFC1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-CD-A48A | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
Top |
Fusion Gene ORF analysis for UGDH-RFC1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000316423 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
In-frame | ENST00000316423 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
5CDS-5UTR | ENST00000316423 | ENST00000418436 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
In-frame | ENST00000501493 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
In-frame | ENST00000501493 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
5CDS-5UTR | ENST00000501493 | ENST00000418436 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
Frame-shift | ENST00000506179 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
Frame-shift | ENST00000506179 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
5CDS-5UTR | ENST00000506179 | ENST00000418436 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-3CDS | ENST00000507089 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-3CDS | ENST00000507089 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-5UTR | ENST00000507089 | ENST00000418436 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-3CDS | ENST00000515398 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-3CDS | ENST00000515398 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
intron-5UTR | ENST00000515398 | ENST00000418436 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000316423 | UGDH | chr4 | 39522970 | - | ENST00000349703 | RFC1 | chr4 | 39322994 | - | 4534 | 505 | 313 | 3228 | 971 |
ENST00000316423 | UGDH | chr4 | 39522970 | - | ENST00000381897 | RFC1 | chr4 | 39322994 | - | 4537 | 505 | 313 | 3231 | 972 |
ENST00000501493 | UGDH | chr4 | 39522970 | - | ENST00000349703 | RFC1 | chr4 | 39322994 | - | 4353 | 324 | 132 | 3047 | 971 |
ENST00000501493 | UGDH | chr4 | 39522970 | - | ENST00000381897 | RFC1 | chr4 | 39322994 | - | 4356 | 324 | 132 | 3050 | 972 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000316423 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - | 0.000169849 | 0.9998301 |
ENST00000316423 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - | 0.000173551 | 0.9998265 |
ENST00000501493 | ENST00000349703 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - | 0.000156393 | 0.9998436 |
ENST00000501493 | ENST00000381897 | UGDH | chr4 | 39522970 | - | RFC1 | chr4 | 39322994 | - | 0.000159958 | 0.99984 |
Top |
Fusion Genomic Features for UGDH-RFC1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for UGDH-RFC1 |
Go to FGviewer for the breakpoints of chr4:39522970-chr4:39322994 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 11_16 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 11_16 | 54.0 | 428.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 11_16 | 54.0 | 495.0 | Nucleotide binding | NAD |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000349703 | 6 | 25 | 402_492 | 240.0 | 1148.0 | Domain | BRCT | |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000381897 | 6 | 25 | 402_492 | 240.0 | 1149.0 | Domain | BRCT | |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000349703 | 6 | 25 | 1120_1124 | 240.0 | 1148.0 | Motif | Nuclear localization signal | |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000381897 | 6 | 25 | 1120_1124 | 240.0 | 1149.0 | Motif | Nuclear localization signal | |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000349703 | 6 | 25 | 650_657 | 240.0 | 1148.0 | Nucleotide binding | ATP | |
Tgene | RFC1 | chr4:39522970 | chr4:39322994 | ENST00000381897 | 6 | 25 | 650_657 | 240.0 | 1149.0 | Nucleotide binding | ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 130_132 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 276_279 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 89_93 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 130_132 | 54.0 | 428.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 276_279 | 54.0 | 428.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 89_93 | 54.0 | 428.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 130_132 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 276_279 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 89_93 | 54.0 | 495.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 11_16 | 0 | 398.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 130_132 | 0 | 398.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 276_279 | 0 | 398.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 89_93 | 0 | 398.0 | Nucleotide binding | NAD |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 129_135 | 54.0 | 495.0 | Region | Allosteric switch region |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 161_165 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 220_224 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 267_273 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 321_325 | 54.0 | 495.0 | Region | Important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 338_339 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 466_494 | 54.0 | 495.0 | Region | Intrinsically disordered |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000316423 | - | 2 | 12 | 88_110 | 54.0 | 495.0 | Region | Intrinsically disordered%3B important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 129_135 | 54.0 | 428.0 | Region | Allosteric switch region |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 161_165 | 54.0 | 428.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 220_224 | 54.0 | 428.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 267_273 | 54.0 | 428.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 321_325 | 54.0 | 428.0 | Region | Important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 338_339 | 54.0 | 428.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 466_494 | 54.0 | 428.0 | Region | Intrinsically disordered |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000501493 | - | 2 | 11 | 88_110 | 54.0 | 428.0 | Region | Intrinsically disordered%3B important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 129_135 | 54.0 | 495.0 | Region | Allosteric switch region |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 161_165 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 220_224 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 267_273 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 321_325 | 54.0 | 495.0 | Region | Important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 338_339 | 54.0 | 495.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 466_494 | 54.0 | 495.0 | Region | Intrinsically disordered |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000506179 | - | 2 | 12 | 88_110 | 54.0 | 495.0 | Region | Intrinsically disordered%3B important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 129_135 | 0 | 398.0 | Region | Allosteric switch region |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 161_165 | 0 | 398.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 220_224 | 0 | 398.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 267_273 | 0 | 398.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 321_325 | 0 | 398.0 | Region | Important for formation of active hexamer structure |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 338_339 | 0 | 398.0 | Region | Substrate binding |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 466_494 | 0 | 398.0 | Region | Intrinsically disordered |
Hgene | UGDH | chr4:39522970 | chr4:39322994 | ENST00000507089 | - | 1 | 11 | 88_110 | 0 | 398.0 | Region | Intrinsically disordered%3B important for formation of active hexamer structure |
Top |
Fusion Gene Sequence for UGDH-RFC1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000316423_ENST00000349703_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(transcript)=4534nt_BP=505nt AGTCTCCCCGCCCCTGAGCCGTGAAGGAAATAGGGACCTGGCCCTGGGCCTTGTGTAGCGGGAGGGGGAGCTAGGAAGCAGCTGAGGGCA GAATCCAGGAGGGCCTGGCTGCGGGGGAATGAAGCCTCCGCCTTCGCAGGCAAAAGCCTTTAAATACGGGCTCAGGCCCGGGACTCAGAG TGTAACGCGTGGCAGCCTGAGGGAGGGGCGTGCGCCGAGAGGGAGCTCAGATCGAGCGGGGCGCGGGTGGAGAAGCTGCGGCGGCGCGGC CCGTAGGAAGGTGCTGTCCGAACGATCGGGATAGGAGCGGTCCCTGCGCTTGCTGCTGGGAAGTGGTACAATCATGTTTGAAATTAAGAA GATCTGTTGCATCGGTGCAGGCTATGTTGGAGGACCCACATGTAGTGTCATTGCTCATATGTGTCCTGAAATCAGGGTAACGGTTGTTGA TGTCAATGAATCAAGAATCAATGCGTGGAATTCTCCTACACTTCCTATTTATGAGGCTCGAAAGGACACAGAAGCGGGAGAAACGTTTTC ATCTGTCCAAGCCAATTTAAGTAAAGCAGAAAAACATAAATATCCTCATAAAGTAAAAACAGCACAAGTTTCAGATGAAAGAAAGAGCTA CAGTCCTAGGAAGCAAAGTAAATATGAAAGTTCAAAAGAATCTCAGCAACATTCCAAGTCATCAGCTGACAAAATAGGAGAAGTCTCTTC TCCCAAGGCCAGTTCTAAGCTGGCAATTATGAAAAGAAAAGAAGAGAGCTCTTATAAAGAAATAGAGCCTGTGGCCTCAAAAAGAAAAGA AAATGCCATTAAATTGAAAGGAGAGACAAAAACTCCTAAGAAAACCAAAAGTTCTCCAGCTAAAAAAGAGTCTGTAAGTCCTGAAGATTC TGAAAAGAAACGCACTAATTATCAAGCTTATCGAAGCTACTTAAATCGAGAAGGTCCCAAGGCTCTGGGCTCCAAAGAAATACCAAAGGG AGCTGAAAATTGCTTGGAAGGCCTTATATTTGTAATCACAGGCGTGCTGGAGTCTATTGAACGAGATGAGGCCAAGTCTCTAATTGAACG TTATGGGGGAAAAGTAACAGGAAATGTCAGCAAGAAAACAAATTATCTTGTCATGGGTCGTGATAGTGGACAGTCCAAGAGTGATAAGGC CGCAGCCTTGGGGACAAAAATTATTGATGAAGATGGCCTGTTGAATCTGATTCGGACTATGCCAGGCAAGAAATCCAAGTATGAAATAGC AGTTGAAACTGAGATGAAGAAAGAGTCCAAACTGGAGAGAACACCCCAAAAAAATGTCCAAGGAAAAAGAAAAATTAGTCCATCTAAAAA GGAATCAGAATCTAAAAAGAGCAGGCCGACTTCCAAAAGGGACAGTTTGGCAAAGACAATAAAAAAGGAAACAGATGTGTTTTGGAAAAG CCTGGATTTCAAGGAGCAGGTGGCTGAGGAGACAAGTGGTGACAGCAAGGCTAGGAATTTGGCTGATGACAGCAGTGAAAACAAAGTGGA AAATTTGCTCTGGGTGGATAAATATAAGCCAACCTCGCTCAAGACCATAATTGGACAGCAAGGTGACCAGAGCTGTGCCAACAAACTCCT ACGCTGGCTCCGAAACTGGCAAAAGAGTTCTTCCGAAGATAAAAAACACGCAAAGTTTGGTAAATTTTCCGGCAAAGATGATGGCTCTAG TTTTAAAGCAGCGTTGCTGTCAGGCCCTCCTGGTGTTGGCAAAACCACCACAGCTTCCCTGGTGTGTCAGGAGTTGGGATACAGCTACGT GGAACTGAATGCAAGTGACACCCGGAGTAAGAGCAGTTTGAAGGCGATTGTTGCTGAGTCACTGAACAATACCAGCATCAAAGGCTTTTA TTCAAATGGAGCAGCCTCTTCAGTAAGCACGAAACATGCTCTCATCATGGATGAAGTAGATGGCATGGCAGGCAATGAGGATAGGGGAGG AATTCAGGAATTAATTGGCCTGATAAAACATACTAAAATTCCCATTATTTGTATGTGCAATGATAGAAATCATCCCAAGATTCGCTCTCT GGTTCATTATTGTTTTGATCTTCGTTTTCAAAGACCTCGGGTTGAACAGATTAAGGGTGCTATGATGTCTATTGCATTTAAAGAAGGTTT AAAGATTCCCCCTCCAGCTATGAATGAAATAATTTTGGGAGCCAATCAAGATATCAGACAGGTTTTACATAATCTGAGTATGTGGTGTGC ACGAAGTAAAGCATTAACCTATGACCAGGCCAAAGCTGATTCTCACAGAGCCAAAAAGGATATCAAAATGGGCCCATTTGATGTTGCCCG GAAAGTGTTTGCAGCTGGAGAGGAGACTGCTCACATGTCACTTGTGGACAAGTCAGATCTCTTTTTTCATGATTATTCAATAGCACCCCT CTTCGTCCAGGAAAATTACATACACGTGAAGCCTGTAGCAGCAGGGGGTGACATGAAAAAGCACCTGATGCTTTTAAGCAGAGCAGCAGA CAGCATATGCGATGGTGACCTAGTGGACAGCCAGATCCGGAGTAAGCAAAACTGGAGTCTTCTGCCTGCGCAGGCCATTTATGCCAGTGT TCTTCCTGGAGAGTTGATGAGGGGGTACATGACCCAGTTTCCCACCTTCCCAAGCTGGCTGGGGAAGCACTCGTCTACAGGCAAACATGA TCGTATTGTTCAGGACCTGGCCTTGCATATGAGTCTCAGAACTTACTCCAGCAAAAGGACTGTAAACATGGATTATCTGTCGCTTCTAAG GGATGCACTTGTACAGCCCTTGACCTCACAAGGAGTAGACGGAGTACAGGATGTTGTTGCACTTATGGACACATATTATTTGATGAAAGA AGACTTTGAGAATATCATGGAAATCAGCAGCTGGGGTGGCAAACCTAGTCCCTTTTCAAAGCTGGATCCCAAGGTGAAAGCAGCCTTCAC AAGAGCTTACAATAAGGAAGCCCACCTTACTCCATACTCACTTCAAGCTATAAAGGCATCTAGACACAGCACAAGCCCATCCCTGGATTC GGAATACAATGAAGAATTAAATGAAGATGACTCTCAATCTGATGAGAAAGACCAAGATGCTATAGAAACTGATGCCATGATCAAGAAAAA GACAAAATCTTCAAAGCCTTCAAAACCAGAAAAAGATAAGGAGCCCAGAAAAGGAAAAGGAAAAAGTTCGAAGAAATGAAACCATTTTTC ACTAGCGACAGCCACTTTTTACTCTCCCTCCTGACCAGTCCAGCTGGTCTAGAGAAAGCCTTGTTTTTTCCCAGAGCAACCATGTTTTAG CATAATGGGATGACCTGGTGTCCCATTATAAATAAAGGGTGGTATGGCTAGAAGGGTATGAGCAGTAGGCTTATGTACACCTCTTATAGA GGTTGATAGGACTGCTTGGGTCCTCCACTGTCCTCTGTCAATCTAGTTAGACGTGCTTCTGAATGACTGTAGAATTGGAACTAGAAACTA CACCTGGGCTTTGGAGTCAGATTTTAGTTAACAATAATGAGCCTGGGAGCAGTAGTACTAAGGCGTCTTTTGTAGGCTTAAGAATTTATC CTAATGGCCTTTATAGGACCAATGCTGATTTTTTTTAAAGGCAGTTCCTATTATGTGGTGAAATTTTGTAAATAAATGATTATACAAAAC AGTCACCACCTAGAACTGGGTATTCTTTGTACATTGTCAGATATCTTTCAAAGTATAAATTAGGAATAAAAATGTTCCACATGATATGTG TACAAATTCTTTTTAAGATTGTCATCTTGTACAGCAAAATATTATGTTGGTATATTACTTCCTTATTAATTTGCAAATGATTGGATTAAA AAAGCTCACTGTATTCCTTACTAACCTGTTGTGTGAAACATAACATTGGCAGTCGAGGAGTCAGAACTCGGATTCCCAGCCTCACTCCCT CTGTGTGTGTTGACCACGTCTCTGCTGTGAATAGGATTTCATGCAGTGGTCTGTTATGGGGCTTTGCAGCGTGGGGGGCTGCAGAAGATT CTCAGACATTCTTATCCTTCTGGAGTCTCAACCCATCAGGTTCAGACCAGTAGGAACCAGGCTGGGTCAGGCTCTTAATTTCACTATGGT GGGGGACAAAATGAACACTGGCTTTTGTTCACTTTGCCCCTGAGAGATCTAGTCCTGTCCTGTGATGGCTTCCACAAACCCTGTTGGAAG TTTGGGTTATTCCTATAACTGTATGTGTTGAGTGGCCGTGAGGCTATGGACCTAGCCTGGAATTTAGATGTCTAGCTATTTTTTAATCTT GTTGGTAAATGCTCAGAGGTCTGTGCTACCTCTGTGAGGTATATACTAAAATGAATGTAAAATAAGGATCGTATTCCCTGCTTTAAGGAA CTGGTAGTCTTGTTTGGGTGATGAGACAAAGTTCTTGAGACATTTAAACTGTATTTACCAGTGTGAAAAATGTCATTTATGGAGATTAAT >In-frame_ENST00000316423_ENST00000349703_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(amino acids)=971AA_start in transcript=313_stop in transcript=3228 MRLLLGSGTIMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEARKDTEAGETFSSVQANLSKAEKHKY PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTN YLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDK KHAKFGKFSGKDDGSSFKAALLSGPPGVGKTTTASLVCQELGYSYVELNASDTRSKSSLKAIVAESLNNTSIKGFYSNGAASSVSTKHAL IMDEVDGMAGNEDRGGIQELIGLIKHTKIPIICMCNDRNHPKIRSLVHYCFDLRFQRPRVEQIKGAMMSIAFKEGLKIPPPAMNEIILGA NQDIRQVLHNLSMWCARSKALTYDQAKADSHRAKKDIKMGPFDVARKVFAAGEETAHMSLVDKSDLFFHDYSIAPLFVQENYIHVKPVAA GGDMKKHLMLLSRAADSICDGDLVDSQIRSKQNWSLLPAQAIYASVLPGELMRGYMTQFPTFPSWLGKHSSTGKHDRIVQDLALHMSLRT YSSKRTVNMDYLSLLRDALVQPLTSQGVDGVQDVVALMDTYYLMKEDFENIMEISSWGGKPSPFSKLDPKVKAAFTRAYNKEAHLTPYSL -------------------------------------------------------------- >In-frame_ENST00000316423_ENST00000381897_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(transcript)=4537nt_BP=505nt AGTCTCCCCGCCCCTGAGCCGTGAAGGAAATAGGGACCTGGCCCTGGGCCTTGTGTAGCGGGAGGGGGAGCTAGGAAGCAGCTGAGGGCA GAATCCAGGAGGGCCTGGCTGCGGGGGAATGAAGCCTCCGCCTTCGCAGGCAAAAGCCTTTAAATACGGGCTCAGGCCCGGGACTCAGAG TGTAACGCGTGGCAGCCTGAGGGAGGGGCGTGCGCCGAGAGGGAGCTCAGATCGAGCGGGGCGCGGGTGGAGAAGCTGCGGCGGCGCGGC CCGTAGGAAGGTGCTGTCCGAACGATCGGGATAGGAGCGGTCCCTGCGCTTGCTGCTGGGAAGTGGTACAATCATGTTTGAAATTAAGAA GATCTGTTGCATCGGTGCAGGCTATGTTGGAGGACCCACATGTAGTGTCATTGCTCATATGTGTCCTGAAATCAGGGTAACGGTTGTTGA TGTCAATGAATCAAGAATCAATGCGTGGAATTCTCCTACACTTCCTATTTATGAGGCTCGAAAGGACACAGAAGCGGGAGAAACGTTTTC ATCTGTCCAAGCCAATTTAAGTAAAGCAGAAAAACATAAATATCCTCATAAAGTAAAAACAGCACAAGTTTCAGATGAAAGAAAGAGCTA CAGTCCTAGGAAGCAAAGTAAATATGAAAGTTCAAAAGAATCTCAGCAACATTCCAAGTCATCAGCTGACAAAATAGGAGAAGTCTCTTC TCCCAAGGCCAGTTCTAAGCTGGCAATTATGAAAAGAAAAGAAGAGAGCTCTTATAAAGAAATAGAGCCTGTGGCCTCAAAAAGAAAAGA AAATGCCATTAAATTGAAAGGAGAGACAAAAACTCCTAAGAAAACCAAAAGTTCTCCAGCTAAAAAAGAGTCTGTAAGTCCTGAAGATTC TGAAAAGAAACGCACTAATTATCAAGCTTATCGAAGCTACTTAAATCGAGAAGGTCCCAAGGCTCTGGGCTCCAAAGAAATACCAAAGGG AGCTGAAAATTGCTTGGAAGGCCTTATATTTGTAATCACAGGCGTGCTGGAGTCTATTGAACGAGATGAGGCCAAGTCTCTAATTGAACG TTATGGGGGAAAAGTAACAGGAAATGTCAGCAAGAAAACAAATTATCTTGTCATGGGTCGTGATAGTGGACAGTCCAAGAGTGATAAGGC CGCAGCCTTGGGGACAAAAATTATTGATGAAGATGGCCTGTTGAATCTGATTCGGACTATGCCAGGCAAGAAATCCAAGTATGAAATAGC AGTTGAAACTGAGATGAAGAAAGAGTCCAAACTGGAGAGAACACCCCAAAAAAATGTCCAAGGAAAAAGAAAAATTAGTCCATCTAAAAA GGAATCAGAATCTAAAAAGAGCAGGCCGACTTCCAAAAGGGACAGTTTGGCAAAGACAATAAAAAAGGAAACAGATGTGTTTTGGAAAAG CCTGGATTTCAAGGAGCAGGTGGCTGAGGAGACAAGTGGTGACAGCAAGGCTAGGAATTTGGCTGATGACAGCAGTGAAAACAAAGTGGA AAATTTGCTCTGGGTGGATAAATATAAGCCAACCTCGCTCAAGACCATAATTGGACAGCAAGGTGACCAGAGCTGTGCCAACAAACTCCT ACGCTGGCTCCGAAACTGGCAAAAGAGTTCTTCCGAAGATAAAAAACACGCAGCAAAGTTTGGTAAATTTTCCGGCAAAGATGATGGCTC TAGTTTTAAAGCAGCGTTGCTGTCAGGCCCTCCTGGTGTTGGCAAAACCACCACAGCTTCCCTGGTGTGTCAGGAGTTGGGATACAGCTA CGTGGAACTGAATGCAAGTGACACCCGGAGTAAGAGCAGTTTGAAGGCGATTGTTGCTGAGTCACTGAACAATACCAGCATCAAAGGCTT TTATTCAAATGGAGCAGCCTCTTCAGTAAGCACGAAACATGCTCTCATCATGGATGAAGTAGATGGCATGGCAGGCAATGAGGATAGGGG AGGAATTCAGGAATTAATTGGCCTGATAAAACATACTAAAATTCCCATTATTTGTATGTGCAATGATAGAAATCATCCCAAGATTCGCTC TCTGGTTCATTATTGTTTTGATCTTCGTTTTCAAAGACCTCGGGTTGAACAGATTAAGGGTGCTATGATGTCTATTGCATTTAAAGAAGG TTTAAAGATTCCCCCTCCAGCTATGAATGAAATAATTTTGGGAGCCAATCAAGATATCAGACAGGTTTTACATAATCTGAGTATGTGGTG TGCACGAAGTAAAGCATTAACCTATGACCAGGCCAAAGCTGATTCTCACAGAGCCAAAAAGGATATCAAAATGGGCCCATTTGATGTTGC CCGGAAAGTGTTTGCAGCTGGAGAGGAGACTGCTCACATGTCACTTGTGGACAAGTCAGATCTCTTTTTTCATGATTATTCAATAGCACC CCTCTTCGTCCAGGAAAATTACATACACGTGAAGCCTGTAGCAGCAGGGGGTGACATGAAAAAGCACCTGATGCTTTTAAGCAGAGCAGC AGACAGCATATGCGATGGTGACCTAGTGGACAGCCAGATCCGGAGTAAGCAAAACTGGAGTCTTCTGCCTGCGCAGGCCATTTATGCCAG TGTTCTTCCTGGAGAGTTGATGAGGGGGTACATGACCCAGTTTCCCACCTTCCCAAGCTGGCTGGGGAAGCACTCGTCTACAGGCAAACA TGATCGTATTGTTCAGGACCTGGCCTTGCATATGAGTCTCAGAACTTACTCCAGCAAAAGGACTGTAAACATGGATTATCTGTCGCTTCT AAGGGATGCACTTGTACAGCCCTTGACCTCACAAGGAGTAGACGGAGTACAGGATGTTGTTGCACTTATGGACACATATTATTTGATGAA AGAAGACTTTGAGAATATCATGGAAATCAGCAGCTGGGGTGGCAAACCTAGTCCCTTTTCAAAGCTGGATCCCAAGGTGAAAGCAGCCTT CACAAGAGCTTACAATAAGGAAGCCCACCTTACTCCATACTCACTTCAAGCTATAAAGGCATCTAGACACAGCACAAGCCCATCCCTGGA TTCGGAATACAATGAAGAATTAAATGAAGATGACTCTCAATCTGATGAGAAAGACCAAGATGCTATAGAAACTGATGCCATGATCAAGAA AAAGACAAAATCTTCAAAGCCTTCAAAACCAGAAAAAGATAAGGAGCCCAGAAAAGGAAAAGGAAAAAGTTCGAAGAAATGAAACCATTT TTCACTAGCGACAGCCACTTTTTACTCTCCCTCCTGACCAGTCCAGCTGGTCTAGAGAAAGCCTTGTTTTTTCCCAGAGCAACCATGTTT TAGCATAATGGGATGACCTGGTGTCCCATTATAAATAAAGGGTGGTATGGCTAGAAGGGTATGAGCAGTAGGCTTATGTACACCTCTTAT AGAGGTTGATAGGACTGCTTGGGTCCTCCACTGTCCTCTGTCAATCTAGTTAGACGTGCTTCTGAATGACTGTAGAATTGGAACTAGAAA CTACACCTGGGCTTTGGAGTCAGATTTTAGTTAACAATAATGAGCCTGGGAGCAGTAGTACTAAGGCGTCTTTTGTAGGCTTAAGAATTT ATCCTAATGGCCTTTATAGGACCAATGCTGATTTTTTTTAAAGGCAGTTCCTATTATGTGGTGAAATTTTGTAAATAAATGATTATACAA AACAGTCACCACCTAGAACTGGGTATTCTTTGTACATTGTCAGATATCTTTCAAAGTATAAATTAGGAATAAAAATGTTCCACATGATAT GTGTACAAATTCTTTTTAAGATTGTCATCTTGTACAGCAAAATATTATGTTGGTATATTACTTCCTTATTAATTTGCAAATGATTGGATT AAAAAAGCTCACTGTATTCCTTACTAACCTGTTGTGTGAAACATAACATTGGCAGTCGAGGAGTCAGAACTCGGATTCCCAGCCTCACTC CCTCTGTGTGTGTTGACCACGTCTCTGCTGTGAATAGGATTTCATGCAGTGGTCTGTTATGGGGCTTTGCAGCGTGGGGGGCTGCAGAAG ATTCTCAGACATTCTTATCCTTCTGGAGTCTCAACCCATCAGGTTCAGACCAGTAGGAACCAGGCTGGGTCAGGCTCTTAATTTCACTAT GGTGGGGGACAAAATGAACACTGGCTTTTGTTCACTTTGCCCCTGAGAGATCTAGTCCTGTCCTGTGATGGCTTCCACAAACCCTGTTGG AAGTTTGGGTTATTCCTATAACTGTATGTGTTGAGTGGCCGTGAGGCTATGGACCTAGCCTGGAATTTAGATGTCTAGCTATTTTTTAAT CTTGTTGGTAAATGCTCAGAGGTCTGTGCTACCTCTGTGAGGTATATACTAAAATGAATGTAAAATAAGGATCGTATTCCCTGCTTTAAG GAACTGGTAGTCTTGTTTGGGTGATGAGACAAAGTTCTTGAGACATTTAAACTGTATTTACCAGTGTGAAAAATGTCATTTATGGAGATT >In-frame_ENST00000316423_ENST00000381897_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(amino acids)=972AA_start in transcript=313_stop in transcript=3231 MRLLLGSGTIMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEARKDTEAGETFSSVQANLSKAEKHKY PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTN YLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDK KHAAKFGKFSGKDDGSSFKAALLSGPPGVGKTTTASLVCQELGYSYVELNASDTRSKSSLKAIVAESLNNTSIKGFYSNGAASSVSTKHA LIMDEVDGMAGNEDRGGIQELIGLIKHTKIPIICMCNDRNHPKIRSLVHYCFDLRFQRPRVEQIKGAMMSIAFKEGLKIPPPAMNEIILG ANQDIRQVLHNLSMWCARSKALTYDQAKADSHRAKKDIKMGPFDVARKVFAAGEETAHMSLVDKSDLFFHDYSIAPLFVQENYIHVKPVA AGGDMKKHLMLLSRAADSICDGDLVDSQIRSKQNWSLLPAQAIYASVLPGELMRGYMTQFPTFPSWLGKHSSTGKHDRIVQDLALHMSLR TYSSKRTVNMDYLSLLRDALVQPLTSQGVDGVQDVVALMDTYYLMKEDFENIMEISSWGGKPSPFSKLDPKVKAAFTRAYNKEAHLTPYS -------------------------------------------------------------- >In-frame_ENST00000501493_ENST00000349703_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(transcript)=4353nt_BP=324nt GTAACGCGTGGCAGCCTGAGGGAGGGGCGTGCGCCGAGAGGGAGCTCAGATCGAGCGGGGCGCGGGTGGAGAAGCTGCGGCGGCGCGGCC CGTAGGAAGGTGCTGTCCGAACGATCGGGATAGGAGCGGTCCCTGCGCTTGCTGCTGGGAAGTGGTACAATCATGTTTGAAATTAAGAAG ATCTGTTGCATCGGTGCAGGCTATGTTGGAGGACCCACATGTAGTGTCATTGCTCATATGTGTCCTGAAATCAGGGTAACGGTTGTTGAT GTCAATGAATCAAGAATCAATGCGTGGAATTCTCCTACACTTCCTATTTATGAGGCTCGAAAGGACACAGAAGCGGGAGAAACGTTTTCA TCTGTCCAAGCCAATTTAAGTAAAGCAGAAAAACATAAATATCCTCATAAAGTAAAAACAGCACAAGTTTCAGATGAAAGAAAGAGCTAC AGTCCTAGGAAGCAAAGTAAATATGAAAGTTCAAAAGAATCTCAGCAACATTCCAAGTCATCAGCTGACAAAATAGGAGAAGTCTCTTCT CCCAAGGCCAGTTCTAAGCTGGCAATTATGAAAAGAAAAGAAGAGAGCTCTTATAAAGAAATAGAGCCTGTGGCCTCAAAAAGAAAAGAA AATGCCATTAAATTGAAAGGAGAGACAAAAACTCCTAAGAAAACCAAAAGTTCTCCAGCTAAAAAAGAGTCTGTAAGTCCTGAAGATTCT GAAAAGAAACGCACTAATTATCAAGCTTATCGAAGCTACTTAAATCGAGAAGGTCCCAAGGCTCTGGGCTCCAAAGAAATACCAAAGGGA GCTGAAAATTGCTTGGAAGGCCTTATATTTGTAATCACAGGCGTGCTGGAGTCTATTGAACGAGATGAGGCCAAGTCTCTAATTGAACGT TATGGGGGAAAAGTAACAGGAAATGTCAGCAAGAAAACAAATTATCTTGTCATGGGTCGTGATAGTGGACAGTCCAAGAGTGATAAGGCC GCAGCCTTGGGGACAAAAATTATTGATGAAGATGGCCTGTTGAATCTGATTCGGACTATGCCAGGCAAGAAATCCAAGTATGAAATAGCA GTTGAAACTGAGATGAAGAAAGAGTCCAAACTGGAGAGAACACCCCAAAAAAATGTCCAAGGAAAAAGAAAAATTAGTCCATCTAAAAAG GAATCAGAATCTAAAAAGAGCAGGCCGACTTCCAAAAGGGACAGTTTGGCAAAGACAATAAAAAAGGAAACAGATGTGTTTTGGAAAAGC CTGGATTTCAAGGAGCAGGTGGCTGAGGAGACAAGTGGTGACAGCAAGGCTAGGAATTTGGCTGATGACAGCAGTGAAAACAAAGTGGAA AATTTGCTCTGGGTGGATAAATATAAGCCAACCTCGCTCAAGACCATAATTGGACAGCAAGGTGACCAGAGCTGTGCCAACAAACTCCTA CGCTGGCTCCGAAACTGGCAAAAGAGTTCTTCCGAAGATAAAAAACACGCAAAGTTTGGTAAATTTTCCGGCAAAGATGATGGCTCTAGT TTTAAAGCAGCGTTGCTGTCAGGCCCTCCTGGTGTTGGCAAAACCACCACAGCTTCCCTGGTGTGTCAGGAGTTGGGATACAGCTACGTG GAACTGAATGCAAGTGACACCCGGAGTAAGAGCAGTTTGAAGGCGATTGTTGCTGAGTCACTGAACAATACCAGCATCAAAGGCTTTTAT TCAAATGGAGCAGCCTCTTCAGTAAGCACGAAACATGCTCTCATCATGGATGAAGTAGATGGCATGGCAGGCAATGAGGATAGGGGAGGA ATTCAGGAATTAATTGGCCTGATAAAACATACTAAAATTCCCATTATTTGTATGTGCAATGATAGAAATCATCCCAAGATTCGCTCTCTG GTTCATTATTGTTTTGATCTTCGTTTTCAAAGACCTCGGGTTGAACAGATTAAGGGTGCTATGATGTCTATTGCATTTAAAGAAGGTTTA AAGATTCCCCCTCCAGCTATGAATGAAATAATTTTGGGAGCCAATCAAGATATCAGACAGGTTTTACATAATCTGAGTATGTGGTGTGCA CGAAGTAAAGCATTAACCTATGACCAGGCCAAAGCTGATTCTCACAGAGCCAAAAAGGATATCAAAATGGGCCCATTTGATGTTGCCCGG AAAGTGTTTGCAGCTGGAGAGGAGACTGCTCACATGTCACTTGTGGACAAGTCAGATCTCTTTTTTCATGATTATTCAATAGCACCCCTC TTCGTCCAGGAAAATTACATACACGTGAAGCCTGTAGCAGCAGGGGGTGACATGAAAAAGCACCTGATGCTTTTAAGCAGAGCAGCAGAC AGCATATGCGATGGTGACCTAGTGGACAGCCAGATCCGGAGTAAGCAAAACTGGAGTCTTCTGCCTGCGCAGGCCATTTATGCCAGTGTT CTTCCTGGAGAGTTGATGAGGGGGTACATGACCCAGTTTCCCACCTTCCCAAGCTGGCTGGGGAAGCACTCGTCTACAGGCAAACATGAT CGTATTGTTCAGGACCTGGCCTTGCATATGAGTCTCAGAACTTACTCCAGCAAAAGGACTGTAAACATGGATTATCTGTCGCTTCTAAGG GATGCACTTGTACAGCCCTTGACCTCACAAGGAGTAGACGGAGTACAGGATGTTGTTGCACTTATGGACACATATTATTTGATGAAAGAA GACTTTGAGAATATCATGGAAATCAGCAGCTGGGGTGGCAAACCTAGTCCCTTTTCAAAGCTGGATCCCAAGGTGAAAGCAGCCTTCACA AGAGCTTACAATAAGGAAGCCCACCTTACTCCATACTCACTTCAAGCTATAAAGGCATCTAGACACAGCACAAGCCCATCCCTGGATTCG GAATACAATGAAGAATTAAATGAAGATGACTCTCAATCTGATGAGAAAGACCAAGATGCTATAGAAACTGATGCCATGATCAAGAAAAAG ACAAAATCTTCAAAGCCTTCAAAACCAGAAAAAGATAAGGAGCCCAGAAAAGGAAAAGGAAAAAGTTCGAAGAAATGAAACCATTTTTCA CTAGCGACAGCCACTTTTTACTCTCCCTCCTGACCAGTCCAGCTGGTCTAGAGAAAGCCTTGTTTTTTCCCAGAGCAACCATGTTTTAGC ATAATGGGATGACCTGGTGTCCCATTATAAATAAAGGGTGGTATGGCTAGAAGGGTATGAGCAGTAGGCTTATGTACACCTCTTATAGAG GTTGATAGGACTGCTTGGGTCCTCCACTGTCCTCTGTCAATCTAGTTAGACGTGCTTCTGAATGACTGTAGAATTGGAACTAGAAACTAC ACCTGGGCTTTGGAGTCAGATTTTAGTTAACAATAATGAGCCTGGGAGCAGTAGTACTAAGGCGTCTTTTGTAGGCTTAAGAATTTATCC TAATGGCCTTTATAGGACCAATGCTGATTTTTTTTAAAGGCAGTTCCTATTATGTGGTGAAATTTTGTAAATAAATGATTATACAAAACA GTCACCACCTAGAACTGGGTATTCTTTGTACATTGTCAGATATCTTTCAAAGTATAAATTAGGAATAAAAATGTTCCACATGATATGTGT ACAAATTCTTTTTAAGATTGTCATCTTGTACAGCAAAATATTATGTTGGTATATTACTTCCTTATTAATTTGCAAATGATTGGATTAAAA AAGCTCACTGTATTCCTTACTAACCTGTTGTGTGAAACATAACATTGGCAGTCGAGGAGTCAGAACTCGGATTCCCAGCCTCACTCCCTC TGTGTGTGTTGACCACGTCTCTGCTGTGAATAGGATTTCATGCAGTGGTCTGTTATGGGGCTTTGCAGCGTGGGGGGCTGCAGAAGATTC TCAGACATTCTTATCCTTCTGGAGTCTCAACCCATCAGGTTCAGACCAGTAGGAACCAGGCTGGGTCAGGCTCTTAATTTCACTATGGTG GGGGACAAAATGAACACTGGCTTTTGTTCACTTTGCCCCTGAGAGATCTAGTCCTGTCCTGTGATGGCTTCCACAAACCCTGTTGGAAGT TTGGGTTATTCCTATAACTGTATGTGTTGAGTGGCCGTGAGGCTATGGACCTAGCCTGGAATTTAGATGTCTAGCTATTTTTTAATCTTG TTGGTAAATGCTCAGAGGTCTGTGCTACCTCTGTGAGGTATATACTAAAATGAATGTAAAATAAGGATCGTATTCCCTGCTTTAAGGAAC TGGTAGTCTTGTTTGGGTGATGAGACAAAGTTCTTGAGACATTTAAACTGTATTTACCAGTGTGAAAAATGTCATTTATGGAGATTAATT >In-frame_ENST00000501493_ENST00000349703_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(amino acids)=971AA_start in transcript=132_stop in transcript=3047 MRLLLGSGTIMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEARKDTEAGETFSSVQANLSKAEKHKY PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTN YLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDK KHAKFGKFSGKDDGSSFKAALLSGPPGVGKTTTASLVCQELGYSYVELNASDTRSKSSLKAIVAESLNNTSIKGFYSNGAASSVSTKHAL IMDEVDGMAGNEDRGGIQELIGLIKHTKIPIICMCNDRNHPKIRSLVHYCFDLRFQRPRVEQIKGAMMSIAFKEGLKIPPPAMNEIILGA NQDIRQVLHNLSMWCARSKALTYDQAKADSHRAKKDIKMGPFDVARKVFAAGEETAHMSLVDKSDLFFHDYSIAPLFVQENYIHVKPVAA GGDMKKHLMLLSRAADSICDGDLVDSQIRSKQNWSLLPAQAIYASVLPGELMRGYMTQFPTFPSWLGKHSSTGKHDRIVQDLALHMSLRT YSSKRTVNMDYLSLLRDALVQPLTSQGVDGVQDVVALMDTYYLMKEDFENIMEISSWGGKPSPFSKLDPKVKAAFTRAYNKEAHLTPYSL -------------------------------------------------------------- >In-frame_ENST00000501493_ENST00000381897_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(transcript)=4356nt_BP=324nt GTAACGCGTGGCAGCCTGAGGGAGGGGCGTGCGCCGAGAGGGAGCTCAGATCGAGCGGGGCGCGGGTGGAGAAGCTGCGGCGGCGCGGCC CGTAGGAAGGTGCTGTCCGAACGATCGGGATAGGAGCGGTCCCTGCGCTTGCTGCTGGGAAGTGGTACAATCATGTTTGAAATTAAGAAG ATCTGTTGCATCGGTGCAGGCTATGTTGGAGGACCCACATGTAGTGTCATTGCTCATATGTGTCCTGAAATCAGGGTAACGGTTGTTGAT GTCAATGAATCAAGAATCAATGCGTGGAATTCTCCTACACTTCCTATTTATGAGGCTCGAAAGGACACAGAAGCGGGAGAAACGTTTTCA TCTGTCCAAGCCAATTTAAGTAAAGCAGAAAAACATAAATATCCTCATAAAGTAAAAACAGCACAAGTTTCAGATGAAAGAAAGAGCTAC AGTCCTAGGAAGCAAAGTAAATATGAAAGTTCAAAAGAATCTCAGCAACATTCCAAGTCATCAGCTGACAAAATAGGAGAAGTCTCTTCT CCCAAGGCCAGTTCTAAGCTGGCAATTATGAAAAGAAAAGAAGAGAGCTCTTATAAAGAAATAGAGCCTGTGGCCTCAAAAAGAAAAGAA AATGCCATTAAATTGAAAGGAGAGACAAAAACTCCTAAGAAAACCAAAAGTTCTCCAGCTAAAAAAGAGTCTGTAAGTCCTGAAGATTCT GAAAAGAAACGCACTAATTATCAAGCTTATCGAAGCTACTTAAATCGAGAAGGTCCCAAGGCTCTGGGCTCCAAAGAAATACCAAAGGGA GCTGAAAATTGCTTGGAAGGCCTTATATTTGTAATCACAGGCGTGCTGGAGTCTATTGAACGAGATGAGGCCAAGTCTCTAATTGAACGT TATGGGGGAAAAGTAACAGGAAATGTCAGCAAGAAAACAAATTATCTTGTCATGGGTCGTGATAGTGGACAGTCCAAGAGTGATAAGGCC GCAGCCTTGGGGACAAAAATTATTGATGAAGATGGCCTGTTGAATCTGATTCGGACTATGCCAGGCAAGAAATCCAAGTATGAAATAGCA GTTGAAACTGAGATGAAGAAAGAGTCCAAACTGGAGAGAACACCCCAAAAAAATGTCCAAGGAAAAAGAAAAATTAGTCCATCTAAAAAG GAATCAGAATCTAAAAAGAGCAGGCCGACTTCCAAAAGGGACAGTTTGGCAAAGACAATAAAAAAGGAAACAGATGTGTTTTGGAAAAGC CTGGATTTCAAGGAGCAGGTGGCTGAGGAGACAAGTGGTGACAGCAAGGCTAGGAATTTGGCTGATGACAGCAGTGAAAACAAAGTGGAA AATTTGCTCTGGGTGGATAAATATAAGCCAACCTCGCTCAAGACCATAATTGGACAGCAAGGTGACCAGAGCTGTGCCAACAAACTCCTA CGCTGGCTCCGAAACTGGCAAAAGAGTTCTTCCGAAGATAAAAAACACGCAGCAAAGTTTGGTAAATTTTCCGGCAAAGATGATGGCTCT AGTTTTAAAGCAGCGTTGCTGTCAGGCCCTCCTGGTGTTGGCAAAACCACCACAGCTTCCCTGGTGTGTCAGGAGTTGGGATACAGCTAC GTGGAACTGAATGCAAGTGACACCCGGAGTAAGAGCAGTTTGAAGGCGATTGTTGCTGAGTCACTGAACAATACCAGCATCAAAGGCTTT TATTCAAATGGAGCAGCCTCTTCAGTAAGCACGAAACATGCTCTCATCATGGATGAAGTAGATGGCATGGCAGGCAATGAGGATAGGGGA GGAATTCAGGAATTAATTGGCCTGATAAAACATACTAAAATTCCCATTATTTGTATGTGCAATGATAGAAATCATCCCAAGATTCGCTCT CTGGTTCATTATTGTTTTGATCTTCGTTTTCAAAGACCTCGGGTTGAACAGATTAAGGGTGCTATGATGTCTATTGCATTTAAAGAAGGT TTAAAGATTCCCCCTCCAGCTATGAATGAAATAATTTTGGGAGCCAATCAAGATATCAGACAGGTTTTACATAATCTGAGTATGTGGTGT GCACGAAGTAAAGCATTAACCTATGACCAGGCCAAAGCTGATTCTCACAGAGCCAAAAAGGATATCAAAATGGGCCCATTTGATGTTGCC CGGAAAGTGTTTGCAGCTGGAGAGGAGACTGCTCACATGTCACTTGTGGACAAGTCAGATCTCTTTTTTCATGATTATTCAATAGCACCC CTCTTCGTCCAGGAAAATTACATACACGTGAAGCCTGTAGCAGCAGGGGGTGACATGAAAAAGCACCTGATGCTTTTAAGCAGAGCAGCA GACAGCATATGCGATGGTGACCTAGTGGACAGCCAGATCCGGAGTAAGCAAAACTGGAGTCTTCTGCCTGCGCAGGCCATTTATGCCAGT GTTCTTCCTGGAGAGTTGATGAGGGGGTACATGACCCAGTTTCCCACCTTCCCAAGCTGGCTGGGGAAGCACTCGTCTACAGGCAAACAT GATCGTATTGTTCAGGACCTGGCCTTGCATATGAGTCTCAGAACTTACTCCAGCAAAAGGACTGTAAACATGGATTATCTGTCGCTTCTA AGGGATGCACTTGTACAGCCCTTGACCTCACAAGGAGTAGACGGAGTACAGGATGTTGTTGCACTTATGGACACATATTATTTGATGAAA GAAGACTTTGAGAATATCATGGAAATCAGCAGCTGGGGTGGCAAACCTAGTCCCTTTTCAAAGCTGGATCCCAAGGTGAAAGCAGCCTTC ACAAGAGCTTACAATAAGGAAGCCCACCTTACTCCATACTCACTTCAAGCTATAAAGGCATCTAGACACAGCACAAGCCCATCCCTGGAT TCGGAATACAATGAAGAATTAAATGAAGATGACTCTCAATCTGATGAGAAAGACCAAGATGCTATAGAAACTGATGCCATGATCAAGAAA AAGACAAAATCTTCAAAGCCTTCAAAACCAGAAAAAGATAAGGAGCCCAGAAAAGGAAAAGGAAAAAGTTCGAAGAAATGAAACCATTTT TCACTAGCGACAGCCACTTTTTACTCTCCCTCCTGACCAGTCCAGCTGGTCTAGAGAAAGCCTTGTTTTTTCCCAGAGCAACCATGTTTT AGCATAATGGGATGACCTGGTGTCCCATTATAAATAAAGGGTGGTATGGCTAGAAGGGTATGAGCAGTAGGCTTATGTACACCTCTTATA GAGGTTGATAGGACTGCTTGGGTCCTCCACTGTCCTCTGTCAATCTAGTTAGACGTGCTTCTGAATGACTGTAGAATTGGAACTAGAAAC TACACCTGGGCTTTGGAGTCAGATTTTAGTTAACAATAATGAGCCTGGGAGCAGTAGTACTAAGGCGTCTTTTGTAGGCTTAAGAATTTA TCCTAATGGCCTTTATAGGACCAATGCTGATTTTTTTTAAAGGCAGTTCCTATTATGTGGTGAAATTTTGTAAATAAATGATTATACAAA ACAGTCACCACCTAGAACTGGGTATTCTTTGTACATTGTCAGATATCTTTCAAAGTATAAATTAGGAATAAAAATGTTCCACATGATATG TGTACAAATTCTTTTTAAGATTGTCATCTTGTACAGCAAAATATTATGTTGGTATATTACTTCCTTATTAATTTGCAAATGATTGGATTA AAAAAGCTCACTGTATTCCTTACTAACCTGTTGTGTGAAACATAACATTGGCAGTCGAGGAGTCAGAACTCGGATTCCCAGCCTCACTCC CTCTGTGTGTGTTGACCACGTCTCTGCTGTGAATAGGATTTCATGCAGTGGTCTGTTATGGGGCTTTGCAGCGTGGGGGGCTGCAGAAGA TTCTCAGACATTCTTATCCTTCTGGAGTCTCAACCCATCAGGTTCAGACCAGTAGGAACCAGGCTGGGTCAGGCTCTTAATTTCACTATG GTGGGGGACAAAATGAACACTGGCTTTTGTTCACTTTGCCCCTGAGAGATCTAGTCCTGTCCTGTGATGGCTTCCACAAACCCTGTTGGA AGTTTGGGTTATTCCTATAACTGTATGTGTTGAGTGGCCGTGAGGCTATGGACCTAGCCTGGAATTTAGATGTCTAGCTATTTTTTAATC TTGTTGGTAAATGCTCAGAGGTCTGTGCTACCTCTGTGAGGTATATACTAAAATGAATGTAAAATAAGGATCGTATTCCCTGCTTTAAGG AACTGGTAGTCTTGTTTGGGTGATGAGACAAAGTTCTTGAGACATTTAAACTGTATTTACCAGTGTGAAAAATGTCATTTATGGAGATTA >In-frame_ENST00000501493_ENST00000381897_TCGA-CD-A48A_UGDH_chr4_39522970_-_RFC1_chr4_39322994_length(amino acids)=972AA_start in transcript=132_stop in transcript=3050 MRLLLGSGTIMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEARKDTEAGETFSSVQANLSKAEKHKY PHKVKTAQVSDERKSYSPRKQSKYESSKESQQHSKSSADKIGEVSSPKASSKLAIMKRKEESSYKEIEPVASKRKENAIKLKGETKTPKK TKSSPAKKESVSPEDSEKKRTNYQAYRSYLNREGPKALGSKEIPKGAENCLEGLIFVITGVLESIERDEAKSLIERYGGKVTGNVSKKTN YLVMGRDSGQSKSDKAAALGTKIIDEDGLLNLIRTMPGKKSKYEIAVETEMKKESKLERTPQKNVQGKRKISPSKKESESKKSRPTSKRD SLAKTIKKETDVFWKSLDFKEQVAEETSGDSKARNLADDSSENKVENLLWVDKYKPTSLKTIIGQQGDQSCANKLLRWLRNWQKSSSEDK KHAAKFGKFSGKDDGSSFKAALLSGPPGVGKTTTASLVCQELGYSYVELNASDTRSKSSLKAIVAESLNNTSIKGFYSNGAASSVSTKHA LIMDEVDGMAGNEDRGGIQELIGLIKHTKIPIICMCNDRNHPKIRSLVHYCFDLRFQRPRVEQIKGAMMSIAFKEGLKIPPPAMNEIILG ANQDIRQVLHNLSMWCARSKALTYDQAKADSHRAKKDIKMGPFDVARKVFAAGEETAHMSLVDKSDLFFHDYSIAPLFVQENYIHVKPVA AGGDMKKHLMLLSRAADSICDGDLVDSQIRSKQNWSLLPAQAIYASVLPGELMRGYMTQFPTFPSWLGKHSSTGKHDRIVQDLALHMSLR TYSSKRTVNMDYLSLLRDALVQPLTSQGVDGVQDVVALMDTYYLMKEDFENIMEISSWGGKPSPFSKLDPKVKAAFTRAYNKEAHLTPYS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for UGDH-RFC1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for UGDH-RFC1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for UGDH-RFC1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | UGDH | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | UGDH | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Tgene | RFC1 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | RFC1 | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Tgene | RFC1 | C0007758 | Cerebellar Ataxia | 1 | CTD_human |
Tgene | RFC1 | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Tgene | RFC1 | C0011195 | Dejerine-Sottas Disease (disorder) | 1 | CTD_human |
Tgene | RFC1 | C0019816 | Hereditary, Type VII, Motor and Sensory Neuropathy | 1 | CTD_human |
Tgene | RFC1 | C0027888 | Hereditary Motor and Sensory Neuropathies | 1 | CTD_human |
Tgene | RFC1 | C0029463 | Osteosarcoma | 1 | CTD_human |
Tgene | RFC1 | C0234162 | Cerebellar Dysmetria | 1 | CTD_human |
Tgene | RFC1 | C0234357 | Adiadochokinesis | 1 | CTD_human |
Tgene | RFC1 | C0750994 | Cerebellar Hemiataxia | 1 | CTD_human |
Tgene | RFC1 | C3668822 | Hypermetria (finding) | 1 | CTD_human |
Tgene | RFC1 | C4255193 | Bilateral Vestibulopathy | 1 | CTD_human |
Tgene | RFC1 | C4285893 | Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome | 1 | ORPHANET |